Manufacturing, Topical Drugs

>

Latest News

FDA Approves First Drug for Rare Eye Disease

August 24th 2018

Dompé Farmaceutici’s Oxervate (cenegermin), a topical eye drop, is the first treatment approved by the agency for neurotrophic keratitis, a rare disease affecting the cornea.

Researchers Propose a Portable Biomolecular Manufacturing Method

September 22nd 2016

© 2024 MJH Life Sciences

All rights reserved.